BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 12, 2012
View Archived Issues
New GlyT1 inhibitors patented
Read More
Nuvilex provides information on cell encapsulation technology
Read More
New nanovector platform allows noncovalent assembly of targeted therapeutics
Read More
Promedior closes financing round to advance pipeline
Read More
Dr. Falk Pharma obtains European rights to ulcerative colitis drug candidate
Read More
Dendritic cell-based vaccine is safe in patients with HIV
Read More
Novartis transfers marketing rights for ophthalmic solution
Read More
Taiho Pharmaceutical terminates licensing agreement for antipruritic agent
Read More
Aegerion Pharmaceuticals provides update on lomitapide NDA
Read More
Moberg Derma receives clearance for phase I Limtop trial
Read More
New phosphodiesterase 10A inhibitors reported by Evotec
Read More
Shionogi & Co. presents novel P2X3 and P2X2/3 receptor antagonists
Read More
Avedro submits NDA for corneal cross-linking system
Read More
S&T Global designs novel candidate antivirals
Read More
New PARP-1 inhibitors with anticancer potential developed in China
Read More
Roche divulges new seprase-specific antibodies
Read More
Research at Glycotope results in new potential cancer immunotherapies
Read More
Novel candidate schizophrenia therapeutics identified
Read More
Novel RIPK2 inhibitors reported by GlaxoSmithKline
Read More
Roche describes novel potential cancer therapeutics
Read More
Janssen unblinds phase III Zytiga study
Read More
Teva and OncoGenex amend custirsen advanced prostate cancer program
Read More
BioMarin completes enrollment in phase III BMN-110 trial
Read More
Transparency Life Sciences in-licenses ACE inhibitor
Read More
Novo Nordisk seeks Japanese approval for insulin degludec/insulin aspart coformulation
Read More
Peregrine reports topline clinical data on bavituximab
Read More
Inviragen reports topline results from HFMD vaccine study
Read More